Verdiva Bio’s once-a-week oral GLP-1 drug is ready for Phase 2 testing. The drug, made with a proprietary technology that enables oral dosing, was licensed from Sciwind Biosciences. The post Metabolic Meds Startup Verdiva Launches With $410M and a Weekly Oral GLP-1 Drug appeared first on MedCity News.
Collecting payments from patients has always been tough. Confusing bills, missed reminders and affordability concerns often lead to delays. Billing teams get bogged down in follow-up calls and paperwork, leaving little time for complex cases and a big question mark over whether they’re using their time efficiently. As patients shoulder a greater share of their…
Evvy has launched a new line of prescription products to relieve vaginal discomfort. The products are available on the company’s website, with prices ranging from $35 to $59. The post Evvy Introduces Treatments for Common Vaginal Symptoms appeared first on MedCity News.
The goal of the Two-Midnight Rule, originally introduced under traditional Medicare Part A, was to reduce hospital admissions and to ensure the appropriate use of inpatient versus outpatient observation status. Here are some challenges and best practices. The post Navigating Medicare Advantage Compliance One Year After the Two-Midnight Rule appeared first on MedCity News.
Seaport Therapeutics’ Series B financing was one of the largest rounds of funding in our recap of biotech financing news, which spans startups developing drugs for neurological diseases, cancer, immunology, and more. The post Seaport Therapeutics Secures $225M for New Kind of Depression Drug appeared first on MedCity News.
This brief provides an overview of the DACA program, discusses its status and potential impacts of the ACA Marketplace expansion to DACA recipients, and highlights key issues to consider.
Inspired by the speed and ease of at-home Covid-19 tests, OncoSwab is developing a test for lung cancer that detects signs of the disease from a nasal swab. The test could become an alternative to the medical imaging currently used to screen for lung cancer. The post Startup OncoSwab Aims to Make Lung Cancer Detection…
Israeli cancer diagnostics startup SpoititEarly launched in the U.S. It is developing a test that uses AI and trained canines to analyze patients’ breath samples, with the goal of detecting cancer at its earliest stages. The company plans to begin selling the at-home test to U.S. consumers next year. The post Meet the Startup Using…